Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 4, 2026

Ladder Capital's Asset Management Head Sells 35,000 Shares — What's Really at Stake?

View original at finance.yahoo.com
Ladder Capital's Asset Management Head Sells 35,000 Shares — What's Really at Stake? On May 29 and June 2, 2026, Robert Perelman, Head of Asset Management at Ladder Capital Corp (NYSE:LADR), reported the open-market sale of 35,000 shares of Common Stock, according to a SEC Form 4 filing…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This transaction accounted for 7.55% of Perelman's direct Common Stock position, reducing his direct holdings from 463,684 to 428,684 shares.

    60% confidence
  • Over the past two years, Perelman executed two open-market sales totaling 60,000 shares; the 35,000-share transaction is his largest individual direct sale in that period, with the prior sale involving 25,000 shares.

    60% confidence
  • Perelman continues to hold 428,684 shares of Common Stock directly, supporting a continuing alignment with shareholders.

    60% confidence
  • No indirect holdings or derivative securities were involved; all shares sold were held directly, with no involvement from trusts, LLCs, or derivative securities.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com